Why does secondary hyperparathyroidism occur in chronic kidney disease?

Why Secondary Hyperparathyroidism Occurs in Chronic Kidney Disease

Secondary hyperparathyroidism in CKD develops because failing kidneys cannot produce adequate 1,25-dihydroxyvitamin D (calcitriol), leading to reduced intestinal calcium absorption, hypocalcemia, and impaired suppression of parathyroid hormone synthesis, while simultaneously retaining phosphate—all of which drive compensatory parathyroid gland hyperplasia and excessive PTH secretion. 1

Primary Pathophysiologic Mechanisms

The development of secondary hyperparathyroidism follows a predictable cascade that begins early in CKD:

Calcitriol Deficiency

• Reduced plasma levels of 1,25(OH)₂D occur as kidney function declines, representing the earliest and most critical abnormality 1
• This calcitriol deficiency causes two major problems:
  • Decreased intestinal calcium absorption, contributing to hypocalcemia 1
  • Impaired suppression of the parathyroid gene that initiates PTH synthesis 1
• The parathyroid glands lose their normal feedback mechanism, as calcitriol normally acts on vitamin D receptors to suppress PTH production 2

Phosphate Retention

• Phosphate retention occurs very early in CKD (probably Stage 1, definitely Stage 2), even before serum phosphorus becomes elevated 1
• Phosphate has a direct effect on PTH secretion independent of calcitriol or calcium levels, particularly in advanced renal insufficiency 2
• Hyperphosphatemia stimulates PTH secretion and promotes parathyroid gland hyperplasia 3

Hypocalcemia

• Low serum calcium results from both decreased intestinal absorption (due to calcitriol deficiency) and phosphate retention 1, 4
• Hypocalcemia directly stimulates PTH secretion through the calcium-sensing receptor 5
• A shift in the set-point for calcium-regulated PTH secretion occurs, requiring much higher calcium concentrations to suppress PTH release 2

Progressive Nature and Timing

PTH levels begin rising when GFR falls below 60 mL/min/1.73 m² (CKD Stage 3), even when serum phosphorus remains normal 1, 6. This progression follows a characteristic pattern:

• In early CKD (Stages 1-2): Calcitriol deficiency and calcium-sensing receptor abnormalities predominate 4
• In moderate CKD (Stage 3): Secondary hyperparathyroidism becomes evident with elevated PTH despite normal serum phosphorus 1
• In advanced CKD (Stages 4-5): Hyperphosphatemia emerges as an additional critical pathogenic factor 4

Parathyroid Gland Changes

The parathyroid glands undergo compensatory hyperplasia in response to these metabolic derangements 7, 3. Critical cellular changes include:

• Downregulation of vitamin D receptors in hyperplastic parathyroid tissue, making the glands less responsive to calcitriol therapy 1
• Downregulation of calcium-sensing receptors, reducing sensitivity to calcium-mediated PTH suppression 3
• Development of nodular hyperplasia in severe cases, which becomes increasingly refractory to medical management 1

Role of FGF-23

Fibroblast growth factor 23 (FGF-23) increases early in CKD and contributes to secondary hyperparathyroidism 3. FGF-23 suppresses calcitriol production by inhibiting 1-alpha-hydroxylase activity in the kidneys, further exacerbating vitamin D deficiency 3.

Clinical Implications

The pathophysiology explains why secondary hyperparathyroidism often progresses despite treatment 1:

• Severe hyperparathyroidism (intact PTH >1,000 pg/mL) requires larger vitamin D sterol doses and longer treatment periods (>12-24 weeks) 1
• The delayed response relates to upregulation requirements for vitamin D receptors that are reduced in nodular parathyroid glands 1
• When intact PTH exceeds 500-600 pg/mL, moderate to severe hyperparathyroid bone disease is typical 1

Common Pitfalls

Clinicians must recognize that normal or low-normal serum phosphorus in early CKD does not exclude phosphate retention as a pathogenic factor 1. Additionally, "normal" 1,25(OH)₂D levels in the face of elevated PTH represent inappropriate levels and contribute to defective feedback suppression 1.